Cancer Family
Central Nervous System Neoplasm
CI-CAN-00000118Explore in graph →
Non-malignant1,345 active trials7 approved drugs177 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000118Explore in graph →
Clinical trials
5,060 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03879512 | Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG | completed | Phase 1 / Phase 2 | 24 | Wuerzburg University HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06600399 | Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma(PSMA，ASL，PET) | completed | — | 26 | Lanzhou University Second HospitalOTHER |
| 1 |
| Sep 19, 2024 |
| clinicaltrials |
| NCT03995706 | Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0 | completed | Early Phase 1 | 26 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT03052738 | Medical Marijuana in the Pediatric Central Nervous System Tumor Population | completed | — | 19 | University of Colorado, DenverOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT01204684 | Dendritic Cell Vaccine for Patients With Brain Tumors | completed | Phase 2 | 24 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT04013672 | Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence | completed | Phase 2 | 41 | David PeereboomOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT03284268 | Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma(RTB) | completed | N/A | 13 | Fundació Sant Joan de DéuOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT04171895 | Communication Training for Caregivers In Advanced Care Planning | completed | — | 49 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT05095766 | Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis Diagnosis(ITIRR) | completed | — | 40 | Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT01923922 | CT Perfusion in the Prognostication of Cerebral High Grade Glioma | completed | N/A | 48 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06562621 | Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma | completed | Phase 1 / Phase 2 | 38 | Beijing Neurosurgical InstituteOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06563024 | 18F-FET PET/CT in the Management of Glioma | completed | N/A | 36 | Buddhist Tzu Chi General HospitalOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT01445314 | Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments | completed | — | 598 | National Cancer Institute (NCI)NIH | 1 | Aug 16, 2024 | clinicaltrials |
| NCT04492163 | Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM | completed | Phase 2 | 25 | NovoCure GmbHINDUSTRY | 1 | Aug 16, 2024 | clinicaltrials |
| NCT04067960 | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer | completed | Early Phase 1 | 197 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06526481 | Nasoseptal Double Flap Versus Rescue Flap in Endoscopic Transsphenoidal Pituitary Surgery | completed | N/A | 56 | Mansoura UniversityOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT05977738 | Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin(ReDiReCCT-Pita) | completed | Early Phase 1 | 12 | C.DirvenOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT00601003 | Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma | completed | Phase 2 | 112 | Giselle ShollerOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT00867568 | TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma | completed | Phase 1 | 18 | Giselle ShollerOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT01802567 | Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer | completed | N/A | 52 | Giselle ShollerOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT03407781 | IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade Glioma | completed | Phase 1 | 52 | Deling LiOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT04497142 | Effect of Perampanel on Peritumoral Hyperexcitability in HGG | completed | Phase 1 / Phase 2 | 12 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06538428 | Methylation Patterns of the NUPR1, MGMT, NDRG2, and GLI1 Genes and Their Impact on Therapeutic Outcome of GBM Patients | completed | — | 78 | Ain Shams UniversityOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06038604 | Glioblastoma Psychosocial Support Program | completed | N/A | 11 | Duke UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05202925 | Musical Training Programme to Improve Neurocognitive Functioning of Children Surviving Brain Tumours | completed | N/A | 40 | The Hong Kong Polytechnic UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06454266 | First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen) | completed | Phase 2 | 22 | Ningbo No. 1 HospitalOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT02846038 | Understanding Communication in Healthcare to Achieve Trust (U-CHAT) | completed | — | 138 | St. Jude Children's Research HospitalOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT03493932 | Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade | completed | Phase 1 | 21 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Jul 24, 2024 | clinicaltrials |
| NCT03636568 | Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)(DHAPS) | completed | N/A | 300 | Washington University School of MedicineOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT02441322 | Evaluating Therapeutic Response to Novo-TTF | completed | N/A | 30 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT01817751 | Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma | completed | Phase 2 | 47 | Virginia Commonwealth UniversityOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT03398694 | Pre-operative Stereotactic Radiosurgery Followed by Resection for Patients With Brain Metastases | completed | N/A | 50 | Indiana UniversityOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT01244737 | FLT-PET Imaging of Brain Tumors in Children | completed | Phase 2 | 50 | Frederick Daniel GrantOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT06490497 | Expectations and Needs of a Glioblastoma Caregiver(GLOIOS) | completed | — | 9 | Hopital Nord Franche-ComteOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT01657734 | Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell Therapy | completed | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT04461002 | Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas. | completed | — | 22 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06346821 | Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data | completed | — | 181 | Sichuan UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05025969 | Evaluation of the Incidence of NTRK Gene Fusion in Adult Brain Tumours(NTRK Fusion) | completed | — | 140 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT05538572 | A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors | completed | Phase 1 | 22 | Prelude TherapeuticsINDUSTRY | 2 | Jul 1, 2024 | clinicaltrials |
| NCT03579602 | Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery | completed | Phase 2 / Phase 3 | 118 | Blaze Bioscience Inc.INDUSTRY | 1 | Jun 27, 2024 | clinicaltrials |
| NCT04101123 | Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas(SUPATEEN) | completed | — | 68 | Martin-Luther-Universität Halle-WittenbergOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT01556230 | Prospective Study of Clinically Nonfunctioning Pituitary Adenomas(PAPS) | completed | — | 292 | Columbia UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT04937413 | The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation | completed | Early Phase 1 | 32 | Duke UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT03038308 | Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole | completed | Phase 1 / Phase 2 | 16 | Columbia UniversityOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT03434262 | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors | completed | Phase 1 | 68 | St. Jude Children's Research HospitalOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT02014844 | Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma | completed | Phase 2 | 28 | ImmunityBio, Inc.INDUSTRY | 1 | May 29, 2024 | clinicaltrials |
| NCT04752267 | 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases | completed | Early Phase 1 | 10 | University of Southern CaliforniaOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT05236829 | Exercise Capacity and Physical Activity Level in Prolactinoma Patients | completed | — | 38 | Hacettepe UniversityOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT04079595 | Closed vs. Open Face Masks for Cranial Radiotherapy | completed | N/A | 60 | University of ZurichOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT05402241 | IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study(IRD-GBM) | completed | — | 52 | University of ManitobaOTHER | 1 | May 23, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Sep 19, 2024source: clinicaltrials